Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Nbn
REST API REST API
Mus musculus
Nbn is differentially expressed in 161 experiments: 75 organism parts: liver, hippocampus, ... (73 more);, 8 disease states: normal, 3-NP-induced neurodegeneration model of Huntington's disease, ... (6 more);, 37 cell types 16 cell lines 26 compound treatments and 30 other conditions.
Synonyms 'Nbs1'
Orthologs NBN (Gallus gallus)   Nbn (Rattus norvegicus)   ENSCING00000002421 (Ciona intestinalis)   NBN (Bos taurus)   NBN (Homo sapiens)   nbs (Drosophila melanogaster)   nbn (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term chromosome, telomeric region, telomere maintenance, DNA damage checkpoint, protein binding, apoptosis, DNA repair, cell proliferation, damaged DNA binding, Mre11 complex, intracellular, meiosis, positive regulation of cell proliferation, protein N-terminus binding, replication fork, double-strand break repair, transcription factor binding, DNA duplex unwinding, nuclear chromosome, telomeric region, cell cycle, nucleus, ATP-dependent DNA helicase activity, response to drug, chromosome, response to DNA damage stimulus, nucleolus, nuclear inclusion body, regulation of fibroblast proliferation, in utero embryonic development, blastocyst growth, mitotic cell cycle G2/M transition DNA damage checkpoint, neuromuscular process controlling balance, negative regulation of neuron differentiation, G2/M transition checkpoint, isotype switching, positive regulation of kinase activity, positive regulation of protein autophosphorylation, mitotic cell cycle G1/S transition checkpoint
InterPro Term Nibrin_met, FHA_dom, DNA-repair_Nbs1_C
Search EB-eye ENSMUSG00000028224
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-MEXP-114, E-GEOD-1479, E-TABM-865, E-GEOD-20160, ... (41 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-21515, E-GEOD-19732, E-GEOD-1956, E-GEOD-10246, E-MEXP-1361, ... (8 experiments)

Factor Value U/D Experiments
N1E-115 wild_type
1
E-GEOD-1956
4T1
1
E-GEOD-11259
N1E-115 Tcof1 overexpressed
1
E-GEOD-1956
M-27
1
E-MEXP-1361
IP14D-101
1
E-GEOD-21515
Swiss5
1
E-GEOD-19732
10 more value(s).


Cell type

studied in E-GEOD-19401, E-GEOD-2585, E-GEOD-7069, E-GEOD-21749, E-TABM-130, ... (17 experiments)

Factor Value U/D Experiments
hematopoietic stem cell
2
E-MEXP-1158, E-GEOD-7069
olfactory bulb
1
E-GEOD-10246
mammary luminal ER+ cell
1
E-TABM-683
mammary luminal ER- cell
1
E-TABM-683
cortical thymic epithelial cell
1
E-GEOD-2585
CD80 high medullary thymic epithelial
1
E-GEOD-2585
31 more value(s).


Disease state

studied in E-GEOD-2514, E-GEOD-3583, E-GEOD-1871, E-GEOD-15904

Factor Value U/D Experiments
lung adenocarcinoma
1
E-GEOD-2514
3-NP-induced neurodegeneration model of Huntington's disease
1
E-GEOD-3583
LPS-induced acute lung injury
1
E-GEOD-1871
mouse model of Huntington's disease
1
E-GEOD-3583
normal
1
1
E-GEOD-3583, E-GEOD-2514
reference
1
E-GEOD-1871
2 more value(s).


Compound treatment

studied in E-GEOD-21927, E-TABM-903, E-GEOD-3296, E-GEOD-4671, E-GEOD-3858, ... (14 experiments)

Factor Value U/D Experiments
none
4
E-MEXP-1237, E-GEOD-5304, E-MEXP-703, E-GEOD-21927
2,3-benzofuran
1
1
E-GEOD-5128
lipopolysaccharide
1
E-GEOD-10246
ethanol
1
E-GEOD-3296
bezafibrate
1
E-GEOD-20513
trichostatin A and dipyridyl
1
E-GEOD-3296
20 more value(s).


Amount to core

studied in E-GEOD-18858

Factor Value U/D Experiments
15
1
E-GEOD-18858
50
1
E-GEOD-18858


cell population
studied in E-GEOD-26086

Clinical treatment
studied in E-GEOD-2411

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-5668, E-GEOD-1026, E-GEOD-16533, E-GEOD-4870, E-GEOD-8191, ... (18 experiments)

dose or concentration
studied in E-GEOD-18858

Genotype
studied in E-GEOD-16533, E-GEOD-20335, E-TABM-102, E-MEXP-1649, E-TABM-285, ... (19 experiments)

Growth condition
studied in E-GEOD-934, E-GEOD-339

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Individual
studied in E-GEOD-18858

Infection
studied in E-GEOD-4324, E-MEXP-1942

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Observation
studied in E-GEOD-3594

Organism
studied in E-MEXP-667

Protocol type
studied in E-GEOD-16192, E-GEOD-2917

Rna integrity number
studied in E-GEOD-18858

Route of exposure
studied in E-GEOD-18858

Sampling time point
studied in E-GEOD-4356

Stimulus or stress
studied in E-GEOD-15902

Strain or line
studied in E-GEOD-17936, E-TABM-865, E-GEOD-21927, E-TABM-671, E-MTAB-76, ... (7 experiments)

Transfect
studied in E-GEOD-6487

Treatment
studied in E-GEOD-18344, E-GEOD-22009, E-GEOD-21841, E-MEXP-1899, E-MEXP-1375, ... (9 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.199 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM